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Abstract
Background: Ro ribonucleoprotein particles (Ro RNPs) consist of a non-coding Y RNA bound by Ro60, La and possibly other
proteins. The physiological function of Ro RNPs is controversial as divergent functions have been reported for its different
constituents. We have recently shown that Y RNAs are essential for the initiation of mammalian chromosomal DNA replication,
whereas Ro RNPs are implicated in RNA stability and RNA quality control. Therefore, we investigate here the functional
consequences of RNP formation between Ro60, La and nucleolin proteins with hY RNAs for human chromosomal DNA replication.
Methodology/Principal Findings: We first immunoprecipitated Ro60, La and nucleolin together with associated hY RNAs
from HeLa cytosolic cell extract, and analysed the protein and RNA compositions of these precipitated RNPs by Western
blotting and quantitative RT-PCR. We found that Y RNAs exist in several RNP complexes. One RNP comprises Ro60, La and
hY RNA, and a different RNP comprises nucleolin and hY RNA. In addition about 50% of the Y RNAs in the extract are present
outside of these two RNPs. Next, we immunodepleted these RNP complexes from the cytosolic extract and tested the ability
of the depleted extracts to reconstitute DNA replication in a human cell-free system. We found that depletion of these RNP
complexes from the cytosolic extract does not inhibit DNA replication in vitro. Finally, we tested if an excess of recombinant
pure Ro or La protein inhibits Y RNA-dependent DNA replication in this cell-free system. We found that Ro60 and La proteins
do not inhibit DNA replication in vitro.
Conclusions/Significance: We conclude that RNPs containing hY RNAs and Ro60, La or nucleolin are not required for the
function ofhYRNAsinchromosomalDNAreplicationinahumancell-freesystem,whichcanbemediatedbyYRNAsoutsideof
these RNPs. These data suggest that Y RNAs can support different cellular functions depending on associated proteins.
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Introduction
Ro ribonucleoprotein particles (Ro RNPs) are soluble complex-
es in vertebrate cells which are detected by autoimmune antibodies
from patients suffering from systemic lupus erythematosis or
Sjo ¨gren’s syndrome [1,2]. Ro RNPs consist of a structured non-
coding RNA termed Y RNA, which is bound by the 60 kDa
autoantigen protein Ro60, the 50 kDa autoantigen protein La,
and possibly other proteins. The physiological function of Ro
RNPs is controversial as divergent functions have been reported
for its different constituents.
Y RNAs are RNA polymerase III transcripts of about 100
nucleotides, which fold into characteristic stem-loop structures
[3,4]. They are evolutionarily conserved in vertebrates [5,6].
Human cells express four Y RNAs (hY1, hY3, hY4 and hY5) [1]
and the nucleotide sequence and domain structure of the
representative hY1 RNA is shown in Fig. 1. Y RNAs have an
essential function for the initiation step of chromosomal DNA
replication in mammalian somatic cells [7,8,9,10]. Knockdown of
hY RNAs by RNA interference results in the inhibition of DNA
replication and the cytostatic arrest of cell proliferation [7,8,10].
Additionally, depletion of hY RNAs from human cell extracts
specifically inhibits the initiation step of chromosomal DNA
replication in a mammalian cell-free system [7,9]. This inhibition
can be overcome by the addition of pure Y RNAs. Recently, we
have shown that an evolutionarily conserved double-stranded
RNA motif present in the upper stem of vertebrate Y RNAs is
essential and sufficient for their function in DNA replication in
mammalian cells [10]. These data indicate that Y RNAs are
functionally active, but it is unknown if any of the associated Ro
RNP proteins play a role in DNA replication.
Ro60 protein binds to a highly conserved site on the lower stem
of the Y RNAs [11,12,13], which is distinct from the domain
required for DNA replication [10]. Ro60 has been proposed to
function as a scavenger for mis-folded RNAs in a quality control
pathway for non-coding RNAs [13,14,15]. Y RNAs have been
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studies have indicated partially overlapping binding sites on Ro60
for misfolded RNAs and Y RNAs [13,16]. This function of Ro60,
however, is not essential as Ro60 knockout mice are viable and,
furthermore, derived embryonic stem (ES) cells show no major
proliferation defects [17,18]. Ro60 knockout cells also show
reduced levels of Y RNAs, thus implicating Ro60 in RNA stability
control [17,18,19,20], possibly by providing protection from
exonuclease digestion. Additional studies have demonstrated that
Ro60 binding is a prerequisite for the export of Y RNAs from the
nucleus to the cytoplasm [21,22].
La protein is required for the accurate and efficient
termination of RNA polymerase III transcription and binds the
39 polyuridine tail of newly synthesised RNAs in the nucleus
[23,24,25,26,27]. Unlike most RNA polymerase III transcripts,
mature Y RNAs retain a 39 polyuridine tail and thus Y RNAs are
believed to maintain a stable association with La [1,2,28,29]. La
has also been implicated in many other aspects of non-coding
RNA biogenesis, such as protecting newly synthesised RNA
against exonuclease digestion [27] and the nuclear retention of
RNAs [21]. In addition to Ro60 and La, several other proteins
have also been reported to interact with a subset of hY RNAs
including the multifunctional protein nucleolin, which associates
with the pyrimidine-rich loops of hY1 and hY3 RNA, but not
with hY4 or hY5 [15,30,31].
Here, we investigate the functional consequences of RNP
formation between Ro60, La and nucleolin with hY RNAs for
chromosomal DNA replication. Our data show that RNPs
containing Y RNAs, Ro60, La or nucleolin are not required for
chromosomal DNA replication in a human cell-free system, and
that that Ro60 and La proteins do not inhibit this function.
Results
hY RNAs are present in several distinct RNP complexes in
human cytosolic extract
To confirm that Ro60, La and nucleolin stably interact with hY
RNAs, we first immunoprecipitated these proteins from HeLa
cytosolic cell extract, and then analysed the protein and RNA
compositions of these immunoprecipitates (Fig. 2). Anti-Ro60
antibodies precipitated both Ro60 and La, and anti-La antibodies
also precipitated both of these proteins (Fig. 2A, bottom panel).
Neither anti-Ro60, nor anti-La antibodies co-precipitated nucleo-
lin under these conditions. Conversely, anti-nucleolin antibodies
precipitated nucleolin from the extract, but did not co-precipitate
La (Fig. 2B). To test whether the co-precipitation of Ro60 and La
is mediated by RNA, we treated the extract with RNase A prior to
immunoprecipitation. We have previously shown that this
treatment reduces the levels of hY RNAs in the extract by three
to four orders of magnitude [7]. RNAse treatment did not
Figure 1. Domain structure of human Y RNA. The most stable secondary structure of hY1 RNA is shown as determined by the Mfold v3.2 RNA
algorithm. The four conserved key structural elements, including specific protein binding sites, are indicated.
doi:10.1371/journal.pone.0013673.g001
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panel), suggesting that these proteins either interact directly, or
that the close proximity of the binding sites for Ro60 and La on
the Y RNA protects the underlying associated RNA fragment
from degradation. In any case, these data indicate that Ro60 and
La proteins are present in the same complex, while nucleolin is
present in a separate complex.
Next, we analysed the RNA content of the immunoprecipitates
by quantitative reverse transcription-PCR (qRT-PCR). We
determined the relative amounts of the four hY RNAs, and of
5S rRNA as a specificity control (Fig. 2C). All four hY RNAs were
enriched more than 500 times in anti-Ro60 immunoprecipitates,
compared with mock immunoprecipitates, whereas 5S rRNA was
enriched only about 6 fold. In anti-La immunoprecipitates, hY1
and hY3 RNA were enriched 70–200 fold, hY4 and hY5 RNA
were both enriched more than 500 times, whereas 5S rRNA was
enriched only about 4 fold. In anti-nucleolin immunoprecipitates,
hY1 RNA was enriched more than 500 times, while hY3, hY4,
hY5 RNA and 5S rRNA were enriched between 15–70 times. We
conclude that Ro60 and La stably interact with all four hY RNAs
in cytosolic extract, while nucleolin interacts preferentially with
hY1 RNA (and to a lesser extent with the other three hY RNAs
and 5S rRNA).
Taken together, these data indicate that hY RNAs are present
in several distinct types of RNP complexes in the cytosolic HeLa
cell extract. First, all four hY RNAs are present in [Ro60/La/hY
Figure 2. Human Y RNAs are present in several distinct RNP complexes in cytosolic extract. The indicated proteins were
immunoprecipitated (IP) from HeLa cytosolic extract and associated proteins and RNAs were analysed by Western blotting and qRT-PCR, respectively.
(A) Protein analysis of Ro60 and La IPs. Apparent molecular weights of the precipitated protein bands are shown, the asterisk indicates the IgG heavy
chain. As a reference, 10% of the input cell extract was loaded on the gel. Where indicated, extract was treated with RNase A prior to IP (RNase). (B)
Protein analysis of nucleolin (NCL) IPs. (C) RNA content analysis of the Ro60, La and nucleolin (NCL) IPs. The relative amounts of all four hY RNAs and
5S rRNA in the indicated immunoprecipitates relative to mock immunoprecipitates were determined by qRT-PCR. Mean values of two independent
experiments are shown.
doi:10.1371/journal.pone.0013673.g002
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present in distinct [nucleolin/hY RNA] RNP complexes, which
form preferentially with hY1 RNA. Thus, in the next experiments,
we investigated the functional requirement of these hY-RNP
complexes for chromosomal DNA replication.
[Ro60/La/hY RNA] and [nucleolin/hY RNA] RNP
complexes are not required for the reconstitution of
chromosomal DNA replication in vitro
Y RNAs are essential to functionally reconstitute the initiation
of DNA replication in a human cell-free system [7]. In this system,
isolated late G1 phase template nuclei initiate DNA replication
when incubated in cytosolic extracts from proliferating cells
[32,33]. Nucleolytic degradation of hY RNAs present in the
extract results in an inhibition of the initiation step of
chromosomal DNA replication, which is negated by the re-
addition of purified Y RNAs [7,9]. We therefore used this system
to investigate whether [Ro60/La/hY RNA] RNPs and/or
[nucleolin/hY RNA] RNPs are required for chromosomal DNA
replication.
First, we immunodepleted these complexes from the cytosolic
extract and then tested the ability of these depleted extracts to
reconstitute DNA replication in vitro (Fig. 3). Ro60 and La were
both depleted specifically by La-specific antibodies, while the level
of nucleolin was unaffected (Fig. 3A). Conversely, nucleolin was
specifically depleted by the anti-nucleolin antibodies, while the
levels of Ro60 and La were unaffected (Fig. 3B).
We then tested the ability of these depleted extracts to
reconstitute the initiation of DNA replication in vitro. When
non-depleted cytosolic extract was used as a positive control,
6364% of nuclei replicated in this extract, compared with 564%
in buffer alone (Fig. 3C), in agreement with a previous
characterisation of this system [32]. Mock depletion of the
cytosolic extract with unspecific antibodies did not affect its ability
to initiate DNA replication as 6165% and 5964% of nuclei
replicated in extracts mock-depleted with either mouse or rabbit
IgGs, respectively (Fig. 3C). Specific depletion of either [Ro60/
La/hY RNA] RNPs or [nucleolin/hY RNA] RNPs resulted in
6164% and 5963% of nuclei replicating, respectively. Therefore,
depletion of either of these hY RNA-containing RNPs from
cytosolic extract has no affect on the initiation of DNA replication
in this system, suggesting that they are not required for DNA
replication. Furthermore, these results show that the cytosolic
protein pools of Ro60, La and nucleolin are also not essential for
DNA replication, whether or not these proteins are stably bound
to hY RNAs.
We have previously reported that Y RNAs act redundantly with
each other in the initiation of chromosomal DNA replication [7,9],
due to an evolutionarily conserved double-stranded RNA motif
present in all vertebrate Y RNAs that is essential and sufficient for
DNA replication in this system [10]. Therefore, depletion of either
[Ro60/La/hY RNA] or [nucleolin/hY RNA] RNPs would still be
consistent with redundant roles of either RNP complex in DNA
replication. To exclude this possibility, we co-depleted both
[Ro60/La/hY RNA] and [nucleolin/hY RNA] RNPs from
cytosolic extract (Fig. 4). Ro60, La and nucleolin proteins were
all depleted by .99% as determined by Western blot analysis
(Fig. 4A). We next determined by qRT-PCR the relative amounts
of all four hY RNAs and 5S rRNA remaining in the extract after
this co-depletion (Fig. 4B). The relative level of hY1 RNA was
reduced to 75% of that seen in the mock-depleted extract, while
the relative levels of hY3 and hY5 were reduced to 38%. The
levels of hY4 RNA and 5S rRNA, however, were only marginally
affected. Taking into account the absolute amounts of these hY
RNAs in this cytosolic extract [7], this co-depletion equates to an
overall reduction of hY RNAs to about 50% (i.e. from
125650 nM of hY1-5 RNAs in the undiluted extract [7] down
to about 62625 nM). We conclude that only about half of all hY
RNAs in this cytosolic HeLa cell extract are present in RNP
complexes with Ro60, La or nucleolin.
We then went on to test the ability of this hY RNP-depleted
extract to reconstitute the initiation of DNA replication in vitro
(Fig. 4C). Neither mock depletion, nor [Ro60/La/hY RNA]/
[nucleolin/hY RNA] RNP co-depletion inhibited the initiation of
chromosomal DNA replication in this system as 5961% and
6065% of nuclei of nuclei replicated, respectively. We conclude
Figure 3. The [Ro60/La/hY RNA] and [nucleolin/hY RNA] RNPs
are not required for the reconstitution of chromosomal DNA
replication in vitro. Immunodepletion of hY RNPs from cytosolic
HeLa cell extracts. (A) Depletion of [Ro60/La/hY RNA] RNPs with La-
specific antibodies, and (B) depletion of [nucleolin/hY RNA] RNPs with
nucleolin-specific antibodies. Ro60, La and nucleolin (NCL) were
analysed in the depleted extracts by Western blot analysis. Ponceau
stains are shown as loading controls. For mock depletions, unspecific
mouse IgG2a antibodies were used alongside purified mouse
monoclonal anti-La antibodies, while pre-immune rabbit serum was
used alongside the anti-nucleolin rabbit serum. (C) Functional
reconstitution of chromosomal DNA replication in the immunodepleted
cytosolic extracts. Late G1 phase template nuclei from mimosine-
arrested human EJ30 cells were incubated in the indicated depleted
extracts. Replication buffer and non-depleted cytosolic extract (cyt)
served as negative and positive controls, respectively. Mock M IgG and
R IgG indicate unspecific mouse and rabbit antibodies, as in panels A
and B. Proportions of replicating nuclei were determined by immuno-
florescence microscopy. Mean values of two independent experiments
are shown.
doi:10.1371/journal.pone.0013673.g003
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associated with either Ro60, La or nucleolin, are sufficient to
reconstitute the initiation of chromosomal DNA replication in
vitro.
Ro60 or La proteins do not inhibit chromosomal DNA
replication in vitro
The experiments described above exclude an essential stimu-
latory function for the major Y RNA-binding proteins Ro60 and
La in chromosomal DNA replication in vitro. It nevertheless
remains a possibility that these proteins may negatively regulate
DNA replication. Ro60 and/or La may sequester Y RNAs and
prevent them from functioning in chromosomal DNA replication.
To address this possibility, in the last set of experiments, we
purified recombinant human Ro60 and La proteins and then
tested if they inhibit hY RNA-dependent initiation of chromo-
somal DNA replication in vitro.
Recombinant human Ro60 was expressed as a poly-histidine
tagged protein in E. coli [34], and purified to .99% using Ni-
NTA agarose chromatography (Fig. 5A). Recombinant human La
was expressed as a chitin binding domain fusion protein in E. coli
[34], and purified to .98% homogeneity by affinity chromatog-
raphy on chitin-agarose, followed by elution of the full-length
human La protein after intein-mediated self cleavage (Fig. 5B).
Before using these proteins in replication assays, we first
conducted RNA band-shift assays to test their ability to bind
purified hY1 RNA (Fig. 5C). Recombinant Ro60 and/or La were
incubated with
32P-labelled hY1 RNA in the presence of a ten-fold
molar excess of unlabelled competitor tRNA to inhibit unspecific
binding. Results were analysed on native polyacrylamide gels,
followed by autoradiography. Ro60 and La both resulted both in a
pronounced upwards shift of the hY1 RNA band in the gel. A
four-fold molar excess of Ro60 protein resulted in a shift of about
30–40% of the input hY1 RNA (Fig. 5C, lane 4), whereas
equimolar amounts of La were already sufficient to shift .90% of
the input hY1 RNA (Fig. 5C, lane 6). This result suggests that La
has a higher binding affinity to Y RNAs than Ro60, or that Ro60
may only bind to a fraction of the Y RNAs, such as misfolded ones.
Furthermore, addition of Ro60 and La together resulted in a
super-shift of the hY1 RNA band above the position obtained with
either protein alone (Fig. 5C, compare lane 12 with lanes 4 and 8).
These results demonstrate that both recombinant Ro60 and La
bind hY1 RNA to form ternary [Ro60/La/hY RNA] RNPs in
vitro, indicating that these recombinant proteins are functionally
intact.
In the last set of experiments, we investigated the effects of
recombinant human Ro60 and La proteins on the initiation of
chromosomal DNA replication in vitro. We tested for potential
negative effects of these proteins under conditions of limiting
cytosolic extract, which allow a more sensitive detection of an
inhibition of DNA replication than saturated conditions. The
addition of 40 mg of cytosolic extract resulted in only about half
the maximal number of nuclei replicating in vitro (3369%),
whereas addition of .100 mg led to the saturation of the system
with the maximal number of nuclei replicating (5465%; Fig. 5D),
in agreement with a previous characterisation of the system [32].
We thus titrated recombinant Ro60 or La into the cell free system
in the presence of 40 mg of extract. First, we determined by
Western blotting that 40 ng and 60 ng of endogenous Ro60 and
La were present in the cytosolic extract per 40 mg of total protein,
respectively. (This is equivalent to 160 nM and 300 nM of
endogenous of Ro60 and La, respectively, whilst all four hY RNAs
together are present at 125650 nM in the extract [7]). Pilot
titrations indicated that addition of up to 1 mg of either
recombinant Ro60 or La to these conditions did not inhibit
DNA replication (data now shown). This result indicates that
molar excesses up to 25- or 17-fold of either Ro60 or La protein
over total hY RNAs, respectively, do not inhibit the initiation of
DNA replication in this system. We finally compared directly the
addition of Ro60, La and both of these proteins together to the
Figure 4. Co-depletion of [Ro60/La/hY RNA] and [nucleolin/hY RNA] RNPs does not inhibit chromosomal DNA replication in vitro.
[Ro60/La/hY RNA] and [nucleolin/hY RNA] RNPs were co-depleted with La- and nucleolin-specific antibodies. (A) Protein levels of nucleolin (NCL),
Ro60 and La in the depleted extracts were analysed by Western blotting. Mouse IgG2a antibodies and pre-immune rabbit serum were used together
for the mock depletion. (B) Analysis of hY RNA and 5S rRNA levels remaining in the depleted extract. Proportions of the indicated RNA amounts
remaining in the extract after [Ro60/La/hY RNA] and [nucleolin/hY RNA] RNP co-depletion were determined by qRT-PCR. Data are shown as
percentages of the mock depletion, after normalisation to HPRT mRNA. (C) Functional reconstitution of chromosomal DNA replication in the co-
depleted extract. Percentages of replicating nuclei were determined as described for Fig. 3C. Mean values of two independent experiments are
shown in panels B and C.
doi:10.1371/journal.pone.0013673.g004
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proteins together at 350 ng had any statistically significant effect
on the proportion of nuclei replicating (3468%, 3467%, 3069%,
respectively; two-tailed t-tests, unequal variance: P.0.3, n=15).
We conclude from these data that more than 10-fold molar
excesses of recombinant Ro60 and/or La proteins over the levels
of endogenous hY RNAs do not inhibit chromosomal DNA
replication in vitro.
Discussion
Y RNAs are essential for the initiation of chromosomal DNA
replication in mammalian somatic cell nuclei [7,9]. They were
originally discovered as the RNA constituent of soluble, predom-
inantly cytoplasmic, RNPs containing Ro60, La and nucleolin
proteins [1,2,28,31,35]. As it was unknown if these Y RNA
binding proteins also play a role in DNA replication, we
investigated their function in this process. Our results demonstrate
that all four hY RNAs are present in two distinct types of RNP
complex in a human cytosolic extract: [Ro60/La/hY RNA] RNPs
and [nucleolin/hY RNA] RNPs. We have shown that these RNPs
are not required for chromosomal DNA replication in a cell-free
system. In fact, immunodepletion of these RNPs removes only
about half of the soluble hY RNAs from the extract. As specific
degradation of Y RNAs by targeted ribonucleases inhibits DNA
replication [7,9], we conclude that the hY RNA pools, which are
not associated with either Ro60, La or nucleolin are sufficient for
the initiation of chromosomal DNA replication in vitro. Con-
versely, we have also demonstrated that an excess of exogenous
Ro60 and La does not inhibit DNA replication in vitro. These
results indicate that RNP formation between Y RNAs and Ro60,
La and nucleolin is not required for Y RNA function in DNA
replication, and that these RNPs may thus perform unrelated
functions in the cell.
Distinct hY RNA-containing RNP complexes are present
in cytosolic extract
Antibodies against Ro60 or La specifically precipitated Ro60,
La and all four hY RNAs, indicating the presence of [Ro60/La/
hY RNA] RNP complexes in the HeLa cytosolic extract and
confirming previous reports [28,31,35,36]. Degradation of the
RNAs present in the extract did not abrogate the co-precipitation
of Ro60 and La, also in accordance with a previous report [31].
This is most likely due to the close proximity of the binding sites
for Ro60 and La on the Y RNA, thus protecting the associated
RNA from degradation.
While anti-nucleolin antibodies precipitated nucleolin and all
four hY RNAs, they did not co-precipitate Ro60 or La.
Conversely, anti-Ro60 and anti-La antibodies did not co-
precipitate nucleolin. Furthermore, our results show that nucleolin
is in a complex with 5S rRNA, suggesting that it associates with
additional RNAs, as well as with hY RNAs. In contrast to our
results, Fouraux and colleagues have reported that anti-nucleolin
antibodies precipitated only hY1 and hY3 RNA, but not hY4 or
hY5 RNA, and that nucleolin co-precipitates with Ro60 and La
[31]. These discrepancies regarding nucleolin-RNPs may be due
to the use of different RNA detection methods (qRT-PCR and
Northern blotting, respectively) and to the use of different
antibodies.
[Nucleolin/hY RNA] RNP complexes are not required for
DNA replication
Nucleolin interacts with pyrimidine-rich stretches in the loop
domain of hY RNAs [31,36]. We have previously shown that
deletion of the entire loop domain does not negate the function of
Y RNAs in DNA replication [10]. Here, we have shown by
immunoprecipitation experiments that the [nucleolin/hY RNA]
RNP complexes are not required for DNA replication in vitro,
thus independently confirming that the interaction between
nucleolin and Y RNAs is not required for the function of Y
RNAs in DNA replication.
As result of heat shock or DNA damage, nucleolin rapidly re-
localisesfromthenucleolustothenucleoplasm and formsa complex
with the DNA replication initiation factor RPA [37,38,39,40]. This
complex formation sequesters RPA and inhibits the initiation of
DNA replication and the G1 to S phase transition. It therefore
remainsan interestingpossibility that nucleolin (with RPA) mayalso
sequester Y RNAs under stress conditions in the intact cell, thus
inhibiting the function of Y RNAs in DNA replication under these
conditions.
[Ro60/La/hY RNA] RNP complexes are not required for
DNA replication
The main observation of our immunoprecipitation experiments
and in vitro DNA replication assays is that RNP formation
between hY RNAs, Ro60 and La is not required for Y RNA
function in DNA replication. A potential caveat of these in vitro
results is the lack of confirmation by an independent experimental
approach (e.g. a combined protein knockout in vivo, followed by
DNA replication assays). However, our data do directly confirm
predictions derived from deletion experiments of the respective
protein binding sites from Y RNAs. Ro60 binds to a highly
conserved site on the lower stem of Y RNAs [11,12,29], while La
interacts with the 39 polyuridine tail [28,29]. Deletion of these
binding sites does not inhibit the function of Y RNAs during
chromosomal DNA replication in vitro and in vivo [7,10]. In
contrast, a separate double stranded RNA domain in the upper
stem of vertebrate Y RNAs is essential and sufficient for their
function in DNA replication [10]. Therefore, either immunode-
pletion of the entire [Ro60/La/hY RNA] RNP, or deletion of the
underlying protein binding sites from the hY RNAs have no effect
on Y RNA function in DNA replication. We therefore conclude
that Y RNA function in chromosomal DNA replication and Ro
RNP function are two separable and independent functions of Y
RNAs.
Figure 5. Ro60 and La proteins do not inhibit chromosomal DNA replication in vitro. (A) Protein analysis of purified Ro60 by SDS-PAGE
and silver staining is shown on the left panel and Western blot analysis on the right panel. Positions of the molecular weight markers (kDa) are
indicated. (B) Protein analysis of purified La by SDS-PAGE and Coomassie staining is shown on the left panel and Western blot analysis on the right
panel. (C) Formation of [Ro60/La/hY RNA] RNPs from purified components in vitro.
32P-labelled hY1 RNA was incubated with purified Ro60 and/or La
at the indicated molar ratios in the presence of a 10-fold molar excess of competitor tRNA. Free RNA was separated from RNPs on native 8%
polyacrylamide gels, and radiolabelled RNA was visualised by autoradiography. Positions of free and protein-complexed hY1 RNA are indicated. (D)
Functional reconstitution of chromosomal DNA replication in the presence of excess recombinant Ro60 and/or La. Template nuclei were incubated in
limiting cytosolic extract (40 mg cyt) with recombinant proteins as indicated. Replication buffer and non-limiting cytosolic extract (cyt) were used as
negative and positive controls, respectively. Proportions of replicating nuclei were determined as described for Fig. 3C. Mean values and standard
deviations of n=15–18 independent experiments are shown.
doi:10.1371/journal.pone.0013673.g005
Ro RNPs and DNA Replication
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controversial reports in the literature. Consistent with our Ro60
immunodepletion data, Wolin and colleagues have reported that
Ro60 knockout mice are viable and that derived embryonic stem
cells show no major proliferation defects [17,18]. The levels of
mY1 and mY3 RNA in Ro60-knockout cells, however, are
reduced, yet no major defects in DNA replication or cell
proliferation have been reported [17,18,19,20]. As such, these
latter observations could be interpreted as evidence against an
essential role for Y RNAs in DNA replication. In contrast, our
published data rule out this interpretation, because we have
demonstrated that nucleolytic degradation of Y RNAs directly
inhibits DNA replication in vitro and in vivo [7,8,9,10]. Like the
depletion of Ro RNPs in Ro60 knockout cells, the immunodeple-
tion of Ro RNPs from cell extracts would thus remove a particular
Ro RNP-associated subpopulation of Y RNAs with no function in
DNA replication, whereas nucleolytic degradation would remove
all Y RNAs indiscriminately. Taken together, these data allow the
conclusion that those Y RNAs which are not contained in [Ro60/
La/Y RNA] or [nucleolin/Y RNA] RNPs constitute a functional
relevant pool for DNA replication, while those Y RNAs present in
these RNPs may be involved in unrelated processes such as non-
coding RNA quality control or RNA stability [14,17,19,20].
Here we have determined by quantitative RT-PCR that about
50% of the hY RNAs in the HeLa cytosolic extract are present in
[Ro60/La/hY RNA] or [nucleolin/hY RNA] RNPs and about
50% are therefore outside of these RNPs. This is in contrast to an
earlier report [41], showing by Northern blotting that the
majority, if not all, cytoplasmic Y RNAs are bound by Ro60
and La. It is possible that these differences arise from different
sensitivities of the two RNA detection techniques used. Alterna-
tively, different cells and culture conditions may produce different
expression ratios between Y RNAs and Ro60 or La proteins,
resulting in different proportions of Y RNAs inside and outside of
Ro RNPs. In support of the latter, we have shown that Y RNAs
are significantly up-regulated between 5-13-fold in human cancer
tissues, compared to normal tissues [8]. This observation suggests
that highly proliferative conditions correlate with high Y RNA
expression levels, which may result in higher proportions of Y
RNAs outside of Ro RNPs.
We do not currently know much about the association of these
functionally active Y RNAs with other proteins outside of [Ro60/
La/Y RNA] or [nucleolin/Y RNA] RNPs. As it is highly unlikely
that the Y RNAs exist as naked RNAs without associated proteins,
we therefore speculate that these Y RNAs can associate with
proteins involved in the initiation of chromosomal DNA
replication. We are currently testing this hypothesis by identifying
and characterising novel Y RNA-protein associations in our
laboratory and preliminary results show that this is indeed the
case. The results of this study will be reported elsewhere.
We found that the addition of more than a 10-fold molar excess of
Ro60 and La proteins over the endogenous Y RNA pools did not
inhibittheinitiationofDNAreplication.Ifoneassumesthatthisextra
protein is able to associate with hY RNAs in the extract, one can thus
not rule out entirely that Y RNAs may support DNA replication even
when associated with Ro60 or La. This scenario is, however, unlikely
because La or Ro60 are already present in higher or equimolar
amounts to endogenous Y RNAs in the extract, respectively, whilst
immunodepletion of more than 99% of total La and Ro60 proteins
only removes half of the soluble Y RNAs. It is therefore likely that
excess Ro60 and La would be either outcompeted on the Y RNAs in
the extract by other Y RNA-binding factors involved in DNA
replication, or be bound by additional RNAs with no function in
DNA replication, or remain uncomplexed.
An independent precedence for selective targeting of Y RNAs to
a cellular pathway independently of Ro RNP formation has
recently been reported for retrovirus assembly [19]. Mouse Y
RNAs are selectively encapsidated into Moloney murine leukae-
mia virus (MLV) virions in Ro60-knockout cells as effectively as in
wild-type cells, despite significantly reduced intracellular Y RNA
levels in the knockouts [19]. By analogy, it is therefore likely that a
proportion of cellular Y RNAs is specifically and efficiently
recruited for chromosomal DNA replication without involving Ro
RNPs. The molecular mechanisms involved in the recruitment of
these Y RNAs to intranuclear sites where DNA replication initiates
are currently under investigation in our laboratory.
Materials and Methods
Immunoprecipitation
Cytosolic extract of asynchronously proliferating human HeLa
cells was obtained from Cilbiotech (Mons, Belgium). Extract was
diluted in replication buffer (20 mM K-HEPES pH 7.8, 100 mM
K-acetate, 1 mM DTT, 1 mM EGTA) and pre-depleted with
protein G-agarose or protein A-agarose (both from Roche).
(Where applicable, pre-depleted extract was treated with a final
concentration of 0.3 mg/ml RNase A (Roche).) Pre-depleted
extracts were incubated with the following primary antibodies:
anti-60 (Euro-Diagnostica), anti-La (Santa Cruz sc-80655), and
anti-nucleolin (a gift from Professor Hans Stahl, University of
Homburg/Saar. Germany). Pre-immune rabbit serum and
unspecific IgG2a antibodies from murine myeloma (Sigma
M5409) were used as negative controls. Antibodies were then
precipitated from extracts with protein G-agarose or protein A-
agarose (both from Sigma). Protein content of immunoprecipitates
was determined via SDS-PAGE followed by Western blot analysis
using the same primary antibodies as used for immunoprecipita-
tion. RNA composition was determined by quantitative reverse
transcription-PCR (qRT-PCR) following phenol/chloroform ex-
traction and ethanol precipitation.
Immunodepletion of cytosolic extract
Primary antibodies as used for immunoprecipitation were
coupled to protein G-agarose or protein A-agarose beads by
incubation in replication buffer. Unspecific IgG2a antibodies from
murine myeloma and/or pre-immune serum were used for mock
depletions. These antibody-coupled beads were then incubated
with cytosolic extract in replication buffer to specifically deplete
proteins from the extract. Following three rounds of depletion,
protein content of extracts was determined via SDS-PAGE
followed by Western blot analysis. RNA composition was
determined by qRT-PCR following phenol/chloroform extraction
and ethanol precipitation.
Quantitative reverse transcription-PCR (qRT-PCR)
cDNA libraries were synthesised from RNA preparations of
immunoprecipitates or cell extracts using random primers (Pro-
mega) with the SuperScript II Reverse Transcriptase kit according
to the manufacturer’s protocol (Invitrogen). These cDNA libraries
were then used as the templates for qRT-PCR on the iCycler iQ
platform as described [7]. For RNA-specific cDNA amplification,
pairs of primers for hY1, hY3, hY4, hY5, 5S and hypoxanthine
ribosyltransferase (HPRT) were used as described [7].
The relative amount (AR(IP)) of each hY RNA and 5S rRNA
in immunoprecipitates compared with mock immunoprecipi-
tates was calculated from the threshold cycle (CT)o fe a c h
cDNA amplification by using the following equation: AR(IP)=
2
(CT of mock immunoprecipitate – CT of specific immunoprecipitate).I d e n -
Ro RNPs and DNA Replication
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were used.
In cell extracts, the relative amount (AR(E)) of each RNA was
first calculated from the threshold cycle (CT) of each cDNA
amplification by using the following equation: AR(E)=2
2DCT =
2
2(CT of test RNA – CT of reference RNA). The reference RNA was HPRT
mRNA. After immunodepletion of cytosolic extract, proportions of the
relative amounts of each RNA were normalised against the mock
depleted extract using the following equation: proportion of
AR(E)=2
2(DCT of immunodepleted extract – DCT of mock depleted extract)X 100%.
Expression and purification recombinant Ro60 and La
For expression of Ro60, the E. coli strain C43 was transformed
with the pET28a/his-Ro60 expression vector [34] and grown at
37uC in Lauria broth (LB) to an A600 of 0.5. Isoproypylthioga-
lactoside (ITPG) was added to a final concentration of 0.4 mM,
the temperature was lowered to 25uC and growth continued
overnight. All purification steps were conducted at 4uC. Bacteria
were harvested by centrifugation, washed in PBS, and resus-
pended in 30 ml protein purification buffer (20 mM KPO4,
pH 7.8, 300 mM NaCl) with 0.2% Triton X-100 and lysed by
sonication. The lysate was clarified by centifugation for 20
minutes at 25,0006g. Imidazole was added to the supernatant to
a final concentration of 10 mM, which was then loaded onto Ni-
NTA-agarose (Qiagen), pre-equilibrated in purification buffer
containing 10 mM imidazole. The column was washed with
40 ml purification buffer containing 150 mM imidazole and
Ro60 protein was then eluted with purification buffer containing
600 mM imidazole. The buffer of the eluted protein fractions was
exchanged for protein storage buffer (50 mM KPO4 pH 7.8,
300 mM KCl, 1 mM EGTA, 0.5 mM DTT, 10% glycerol) using
a PD10 column according to the manufacturers protocol (GE
Healthcare), before flash freezing in liquid nitrogen and storing
at 280uC.
For expression of La, E. coli C43 were transformed with the
pTWIN1/La expression vector [34], grown at 37uCi nL Bt oa n
A600 of 0.05. ITPG was added to a final concentration of 1 mM,
the temperature was lowered to 26uC and growth continued for
20 h. All purification steps were conducted at 4uC. Cells were
washed and lysed in 20 mM Tris-Cl pH 7.0, 500 mM NaCl,
1 mM EDTA, 0.1%Tween 20, 20 mM PMSF by sonication on ice.
The lysate was clarified by centifugation for 30 minutes at
20,0006g and loaded onto chitin beads (NEB) and washed in
50 mM Tris-Cl pH 8.8, 1 M NaCl, 1 mM EDTA, 20 mM PMSF.
On-column cleavage was induced by addition of elution buffer
(50 mM Tris-Cl pH 8.8, 500 mM NaCl, 40 mM DTT, 1 mM
EDTA). Eluted protein fractions containing La were pooled,
exchanged to protein storage buffer, flash frozen in liquid nitrogen
and stored at 280uC.
Concentrations of Ro60 and La proteins in human cytosolic
extract were determined by serial dilutions of pure proteins
alongside of cytosolic extract, followed by Western blotting.
RNA band shift assays
Human Y1 RNA was synthesised with SP6 RNA polymerase
from recombinant DNA templates in the presence of a-
32P UTP
as described [7]. For band shift assays, 80 ng of radiolabelled hY1
RNA was incubated in band shift buffer (10 mM Tris-HCl pH 7.5
100 mM NaCl, 3 mM MgCl2, 1 mM DTT) with recombinant
Ro60 and/or recombinant La at molar RNA to protein ratios of
1:0, 1:1, 1:2 or 1:4, and a molar RNA to protein to protein ratio of
1:4:4. Competitor tRNA (Roche) was also added to reactions at 10
fold molar excess of the hY1 RNA to inhibit unspecific binding.
Reactions were incubated for 15 minutes at 37uC before being
loaded onto native 8% polyacrylamide gels (acrylamide:bisacyla-
mide ratio of 180:1), which were run at 4uC. Following
electrophoresis, gels were dried and radiolabelled hY1 RNA was
visualised by autoradiography.
Cell Culture and DNA replication reactions in vitro
Culture of human EJ30 bladder carcinoma cells, cell synchro-
nisation in late G1 phase by mimosine, and preparation of template
nuclei were performed as described [32,42]. Analysis of DNA
replication reactions were performed as described [7,32,43,44].
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